Califf on the controversy over Aduhelm; Senate nears deal to buy Covid vaccines

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Califf admits controversy over FDA's Alzheimer's drug decision impacted experts' trust in the agency By Nicholas Florko Hechler Photographers for STAT "It's pretty clear that the controversy around [Aduhelm] has temporarily impacted the trust in the FDA" by experts, the FDA leader said. Read More Senate nears $10 billion deal to buy Covid vaccines, therapeutics By Rachel Cohrs Win McNamee/Getty Images Top Senate negotiators are nearing a deal to provide the Biden administration with $10 billion to buy vaccines and therapeutics. Read More STAT+: With pharma still struggling in Alzheimer's, health tech companies want a swing By Katie Palmer Adobe The pharmaceutical industry is still struggling to tackle Alzheimer's disease. Now, health tech companies are now trying their hand. Read More Sponsor content by STAT Madness Vote for your favorite team in our sixth-annual STAT Madness bracket — Competition ends soon STAT Madness is a bracket-style tournament to find the best innovations in science and medicine from institutions across the country. Help us decide who progresses to the next round by voting today. Voting closes April 3, 2022. Vote now. STAT+: Biden's high-stakes biomedical science agency ARPA-H will be part of the NIH — but there's a twist By Lev Facher Lydia Polimeni/National Institutes of Health The Biden administration’s new research agency, ARPA-H, will exist as part of the National Institutes of Health — but with a twist. Read More Thursday, March 31, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser